ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,002,616 | -35.1% | 4,359,202 | 0.0% | 0.00% | – |
Q1 2023 | $1,544,901 | +10.4% | 4,359,202 | 0.0% | 0.00% | – |
Q4 2022 | $1,398,868 | -56.0% | 4,359,202 | +0.1% | 0.00% | – |
Q3 2022 | $3,180,000 | -18.7% | 4,356,702 | +0.2% | 0.00% | – |
Q2 2022 | $3,911,000 | -34.2% | 4,346,530 | +9.0% | 0.00% | – |
Q1 2022 | $5,940,000 | -29.7% | 3,986,270 | +2.3% | 0.00% | – |
Q4 2021 | $8,454,000 | -38.7% | 3,895,736 | +0.5% | 0.00% | – |
Q3 2021 | $13,799,000 | -38.5% | 3,875,977 | -0.8% | 0.00% | -100.0% |
Q2 2021 | $22,438,000 | +15.1% | 3,909,046 | +4.1% | 0.00% | 0.0% |
Q1 2021 | $19,495,000 | +201.5% | 3,756,257 | +38.8% | 0.00% | – |
Q4 2020 | $6,467,000 | +142.3% | 2,705,715 | +40.9% | 0.00% | – |
Q3 2020 | $2,669,000 | -23.0% | 1,920,282 | +5.9% | 0.00% | – |
Q2 2020 | $3,464,000 | -0.6% | 1,813,492 | +27.5% | 0.00% | – |
Q1 2020 | $3,484,000 | +19.0% | 1,422,052 | +9.3% | 0.00% | – |
Q4 2019 | $2,928,000 | +6.9% | 1,301,397 | -0.3% | 0.00% | – |
Q3 2019 | $2,740,000 | -22.2% | 1,304,807 | -7.7% | 0.00% | – |
Q2 2019 | $3,521,000 | -29.1% | 1,413,924 | +12.4% | 0.00% | – |
Q1 2019 | $4,967,000 | +956.8% | 1,257,419 | +269.0% | 0.00% | – |
Q4 2018 | $470,000 | -54.2% | 340,724 | -17.0% | 0.00% | – |
Q3 2018 | $1,026,000 | +1.9% | 410,275 | +3.8% | 0.00% | – |
Q2 2018 | $1,007,000 | +34.8% | 395,160 | +11.1% | 0.00% | – |
Q1 2018 | $747,000 | -55.0% | 355,533 | -0.4% | 0.00% | – |
Q4 2017 | $1,659,000 | +64.3% | 356,881 | +166.8% | 0.00% | – |
Q3 2017 | $1,010,000 | +78.8% | 133,747 | +23.1% | 0.00% | – |
Q2 2017 | $565,000 | -3.3% | 108,670 | +11.1% | 0.00% | – |
Q1 2017 | $584,000 | -14.5% | 97,778 | +0.9% | 0.00% | – |
Q4 2016 | $683,000 | +47.5% | 96,878 | +5.4% | 0.00% | – |
Q3 2016 | $463,000 | +46.1% | 91,878 | +3.3% | 0.00% | – |
Q2 2016 | $317,000 | -27.8% | 88,978 | -6.5% | 0.00% | – |
Q1 2016 | $439,000 | – | 95,113 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |